Anogenital electrical stimulation as treatment of urge incontinence in children

G Gladh1, S Mattsson, S Lindström

  • 1Department of Health and Environment, Division of Paediatrics, Faculty of Health Sciences, Linköping, Sweden. gunilla.gladh@lio.se

BJU International
|March 17, 2001
PubMed

Insights

Anogenital afferent stimulation (AGAS) effectively treats therapy-resistant urge incontinence in children. Home-based AGAS complements clinic treatments, improving outcomes for pediatric incontinence.

Area of Science:

  • Pediatric Urology
  • Neurology
  • Rehabilitation Medicine

Background:

  • Urge incontinence in children often presents as therapy-resistant.
  • Bladder instability is a common diagnosis in pediatric incontinence.
  • Anogenital afferent stimulation (AGAS) offers a potential non-invasive treatment modality.

Purpose of the Study:

  • To retrospectively evaluate the efficacy of anogenital afferent stimulation (AGAS).
  • To assess AGAS in neurologically healthy children with treatment-resistant urge incontinence.
  • To determine the impact of home-based AGAS as an adjunct therapy.

Main Methods:

  • Retrospective analysis of 48 children (5-14 years) with cystometry-verified bladder instability.
  • Application of anogenital afferent stimulations using a dual constant-current stimulator.
  • Comparison of pre-treatment and 6-12 month follow-up voiding/incontinence diaries.

Main Results:

  • 18 children were cured, and 7 improved (leakage score halved) after AGAS.
  • Median 9 clinic sessions and 25 home sessions were administered.
  • The treatment was generally well-tolerated by pediatric patients.

Conclusions:

  • Anogenital afferent stimulation is an effective treatment for severe pediatric urge incontinence.
  • Home-based AGAS is a well-accepted adjuvant therapy, enhancing clinical outcomes.
  • AGAS presents a potentially curative option for children with refractory urge incontinence.
Abstract